Menu Menu

AMLX    Amylyx Pharmaceuticals Inc    1658551    
Income Statement
Revenue amlx-20241231 87,371,000
Net Income amlx-20241231 -301,743,000
Profit Margin -345.36%

Balance Sheet
Current Assets 189,432,000
Assets 193,634,000
Current Liabilities 28,406,000
Liabilities 28,869,000
Equity 164,765,000
Shares Out 110,537,000

Cash Flow Statement
Operating Cash Flow -167,647,000
Investing Cash Flow 75,654,000

Market Analysis
Market Cap 1,936,606,538
Price 17.52
BVPS 55.45
PB 0.07
EPS -1.53
PS 0.56
FCF -91,993,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/22 0.07 3/4 -4.43
Apr May Jun
5/09 -1.75
Jul Aug Sep
8/08 -1.07
Oct Nov Dec
11/07

Find a discrepancy? The most accurate way to find company fundamental data is to view AMLX documents filed with the SEC.


AMLX Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas